NCT01473316View on ClinicalTrials.gov

Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Healthy Volunteer

Interventions

DRUG

GDC-0980

Single oral dose

DRUG

Ketoconazole

Repeating Oral Dose

Trial Locations (1)

78744

Austin

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY